Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the studies of left ventricular dysfunction-Reference-Cited by-同舟云学术

Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the studies of left ventricular dysfunction

Published:1999-03 Issue:4 Volume:33 Page:916-923
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Exner Derek V,Dries Daniel L,Waclawiw Myron A,Shelton Brent,Domanski Michael J

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;N Engl J Med,1991

2. Comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure;Cohn;N Engl J Med,1991

3. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS);N Engl J Med,1987

4. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions;N Engl J Med,1992

5. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction;Kober;N Engl J Med,1995

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of undiagnosed stage B heart failure among emergency department patients;The American Journal of Emergency Medicine;2024-11

2. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11

3. The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention;American Journal of Preventive Cardiology;2023-09

4. Artificial intelligence-enabled electrocardiographic screening for left ventricular systolic dysfunction and mortality risk prediction;Frontiers in Cardiovascular Medicine;2023-03-03

5. Targets and management of hypertension in heart failure: focusing on the stages of heart failure;The Journal of Clinical Hypertension;2022-09